Vaccine Notices, Proposed and Final Rules
We have recently redesigned the FDA Web site. As a result, some Web links (URLs) embedded within Guidances, Rules and other documents are no longer valid. If you find a link that does not work, please try searching for the document using the document title. For more assistance, go to Contact FDA.
Federal Register Notice: Determining the Need for and Content of Environmental Assessments for Gene Therapies, Vectored Vaccines, and Related Recombinant Viral or Microbial Products; Guidance
Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order 12/19/2005 Vaccine Adverse Event Reporting System; Revised Form VAERS-2; Availability 11/20/2001
Revision of the Requirements for Live Vaccine Processing; Confirmation of Effective Date Revision of the Requirements for Live Vaccine Processing Revocation of Status of Specific Products; Group A Streptococcus; Confirmation of Effective Date Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review Revocation of Status of Specific Products; Group A Streptococcus